Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Health Industry Watch.
Press releases published on April 23, 2025
AsedaSciences® Partners with Chemspace to Visualize 13 Billion Compounds on 3RnD® Cloud Platform
EIN Presswire
·
April 23, 2025
The world's largest synthesizable chemical library to be visualized in the 3RnD Compound Universe, enabling easy nearest neighbor identification and ordering SCHINDELLEGI, SCHWYZ, SWITZERLAND, April 23, 2025 /EINPresswire.com/ -- AsedaSciences, an …
Orthodontics Market to Hit $26.02 Billion by 2032, Growing at 17.4% CAGR
EIN Presswire
·
April 23, 2025
Leading companies in the orthodontics market are Align Technology, Inc., Solventum, Henry Schein, Inc., DB Orthodontics, and more. NY, UNITED STATES, April 23, 2025 /EINPresswire.com/ -- Orthodontics Market Research Report 2025 - Trends, Forecast …
Atlanta Plastic Surgeons Discuss the Benefits of Breast Augmentation-Mastopexy
EIN Presswire
·
April 23, 2025
Atlanta plastic surgeons Alexandra Hart, MD, FACS and John Connors, MD, FACS share the potential benefits of breast lift surgery when combined with implants. ATLANTA, GA, UNITED STATES, April 23, 2025 /EINPresswire.com/ -- Drs. Alexandra Hart and John …
VetStem, Inc. Achieves Industry Leading Milestone with 40,000 Stem Cell Treatments
EIN Presswire
·
April 23, 2025
Leading regenerative medicine company, VetStem, Inc., has processed over 40,000 stem cell treatments for animals across the United States and Canada. POWAY, CA, UNITED STATES, April 23, 2025 /EINPresswire.com/ -- Leading regenerative veterinary medicine …
Ascentage Pharma To Present Data from Two Clinical Studies at 2025 ASCO Annual Meeting, Including Oral Presentation on Its Key Assets Lisaftoclax and Alrizomadlin
GlobeNewswire
·
April 23, 2025
ROCKVILLE, Md. and SUZHOU, China, April 23, 2025 (GLOBE NEWSWIRE) -- Ascentage Pharma (NASDAQ: AAPG; HKEX: 6855), a global biopharmaceutical company engaged in discovering, developing, and commercializing therapies to address global unmet medical needs …
A Place to Heal: Virtue Recovery Center Stands with Veterans and Families Across the United States
EIN Presswire
·
April 23, 2025
Virtue Recovery Center in Las Vegas works with veterans, offering personalized care for PTSD, addiction, and mental health recovery. LAS VEGAS, NV, UNITED STATES, April 23, 2025 /EINPresswire.com/ -- When military service ends, the journey home doesn’t …
Sen-Jam Showcases Longevity Insights at Global Health Summit in West Palm Beach
EIN Presswire
·
April 23, 2025
Sen-Jam’s Chief Clinical Officer unveils mast cell-driven anti-inflammatory science at elite West Palm Beach summit focused on longevity and wellness. HUNTINGTON, NY, UNITED STATES, April 23, 2025 /EINPresswire.com/ -- Sen-Jam Pharmaceutical Takes the …
CEO of MASORI Therapeutics, Featured in CIO Insightful’s 'The Most Influential Artificial Intelligence Leaders of 2025'
EIN Presswire
·
April 23, 2025
Visionary executive acknowledged for innovative use of AI in transforming legacy pharmaceutical marketing, sales, and engagement strategies HENDERSON, NV, UNITED STATES, April 23, 2025 /EINPresswire.com/ -- Visionary executive acknowledged for …
Aplos Analytics Expands Cloud-Based Platform to Include Custom Outputs
EIN Presswire
·
April 23, 2025
Aplos NCA now supports custom data processing, flexible table and figure creation, and the ability to create custom reports using user-defined templates. OREM, UT, UNITED STATES, April 23, 2025 /EINPresswire.com/ -- Aplos Analytics, a software company …
Mineralys Therapeutics Announces Publication of Pivotal Phase 2 Advance-HTN Results in the New England Journal of Medicine (NEJM)
GlobeNewswire
·
April 23, 2025
– Significant blood pressure reductions among patients with uncontrolled or resistant hypertension treated with lorundrostat reinforce key role of dysregulated aldosterone in disease onset and progression – – Detailed results from the second pivotal Phase …
Supernus Pharmaceuticals to Announce First Quarter 2025 Financial Results and Host Conference Call and Webcast on May 6, 2025
GlobeNewswire
·
April 23, 2025
ROCKVILLE, Md., April 23, 2025 (GLOBE NEWSWIRE) -- Supernus Pharmaceuticals, Inc. (Nasdaq: SUPN), a biopharmaceutical company focused on developing and commercializing products for the treatment of central nervous system (CNS) diseases, today announced …
Aurora Spine Corporation Schedules Release of Fourth Quarter and Fiscal 2024 Financial Results
GlobeNewswire
·
April 23, 2025
CARLSBAD, California, April 23, 2025 (GLOBE NEWSWIRE) -- Aurora Spine Corporation (“Aurora Spine” or the “Company”) (TSXV: ASG) (OTCQB: ASAPF), a leader in spine and interventional spine technology that improves spinal surgery outcomes, today announced it …
Jushi Holdings Inc. to Report First Quarter 2025 Financial Results on May 8, 2025
GlobeNewswire
·
April 23, 2025
BOCA RATON, Fla., April 23, 2025 (GLOBE NEWSWIRE) -- Jushi Holdings Inc. (“Jushi” or the “Company”) (CSE: JUSH) (OTCQX: JUSHF), a vertically integrated, multi-state cannabis operator, announced that it expects to report its financial results for the first …
Aptose Announces Auditor Not Standing for Re-Appointment
GlobeNewswire
·
April 23, 2025
SAN DIEGO and TORONTO, April 23, 2025 (GLOBE NEWSWIRE) -- Aptose Biosciences Inc. (“Aptose” or the “Company”) (TSX:APS), a clinical-stage precision oncology company developing a tuspetinib (TUS) based triple drug frontline therapy to treat patients with …
Amedisys Reports First Quarter 2025 Financial Results
GlobeNewswire
·
April 23, 2025
BATON ROUGE, La., April 23, 2025 (GLOBE NEWSWIRE) -- Amedisys, Inc. (NASDAQ: AMED) today reported its financial results for the three-month period ended March 31, 2025. Three-Month Periods Ended March 31, 2025 and 2024 Net service revenue increased $23.4 …
Xilio Therapeutics to Present Updated Phase 2 Data for Vilastobart, a Tumor-Activated, Fc-Enhanced Anti-CTLA-4, in Combination with Atezolizumab in Patients with Microsatellite Stable Colorectal Cancer at the 2025 ASCO Annual Meeting
GlobeNewswire
·
April 23, 2025
WALTHAM, Mass., April 23, 2025 (GLOBE NEWSWIRE) -- Xilio Therapeutics, Inc. (Nasdaq: XLO), a clinical-stage biotechnology company discovering and developing tumor-activated immuno-oncology therapies for people living with cancer, today announced plans to …
Palvella Therapeutics Announces Abstract Highlighting the Estimated Diagnosed Prevalence and Annual Incidence of Lymphatic Malformations in the U.S. Accepted for Poster Presentation at the 82nd Annual Meeting of the Society for Investigative Dermatology
GlobeNewswire
·
April 23, 2025
Quantitative analysis of medical claims indicates an estimated 44,553 to 92,967 diagnosed U.S. patients with lymphatic malformations (LMs) with cutaneous involvement Estimates of annual incidence of LMs with cutaneous involvement to be highlighted in the …
Iovance Biotherapeutics Announces Participation in Upcoming Scientific Congresses
GlobeNewswire
·
April 23, 2025
SAN CARLOS, Calif., April 23, 2025 (GLOBE NEWSWIRE) -- Iovance Biotherapeutics, Inc. (NASDAQ: IOVA), a biotechnology company focused on innovating, developing, and delivering novel polyclonal tumor infiltrating lymphocyte (TIL) therapies for patients with …
Corvus Pharmaceuticals to Present New Interim Data from Placebo-Controlled Phase 1 Clinical Trial of Soquelitinib for Atopic Dermatitis on May 8, 2025
GlobeNewswire
·
April 23, 2025
Data from Cohorts 1-3 of trial to be presented in an oral session and poster at the Society for Investigative Dermatology (SID) 2025 Annual Meeting Company to discuss data on its first quarter 2025 business update conference call and webcast scheduled for …
Aligos Therapeutics Announces Eight Abstracts Accepted for Presentation at the EASL Congress 2025
GlobeNewswire
·
April 23, 2025
SOUTH SAN FRANCISCO, Calif., April 23, 2025 (GLOBE NEWSWIRE) -- Aligos Therapeutics, Inc. (Nasdaq: ALGS), a clinical stage biopharmaceutical company focused on improving patient outcomes through best-in-class therapies for liver and viral diseases, today …